Sunesis Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SNSS Sunesis Pharmaceuticals Inc
I Intelsat SA
MCK McKesson Corp
BDN Brandywine Realty Trust
C Citigroup Inc
BAC Bank of America Corp
WLL Whiting Petroleum Corp
IQST Iqstel Inc
KDP Keurig Dr Pepper Inc
GROW U.S. Global Investors Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Closing Price
$0.505
Day's Change
-0.0837 (-14.22%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.54
Day's Low
0.50
Volume
(Heavy Day)
Volume:
2,136,168

10-day average volume:
436,095
2,136,168
  • Prev Close
    0.5887
  • Today's Open
    0.501
  • Day's Range
    0.50-0.54
  • Avg Vol (10-day)
    436.1K
  • Last (time)
    3:53p ET 01/18/19
  • Last (size)
    200
  • 52-Wk Range
    0.20 - 7.69
    LowHigh
  • (03/08/18 - 12/21/18)
    152.50%
  • 123.9%
  • Market Cap
    18.9M
  • Shares Outstanding
    37.4M
  • -0.80
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.9
  • 63.90
  • (% of float 12/31/18)
    0.78

Latest News

January 18, 2019
9:58 pm ET
Globe Newswire
January 17, 2019
4:04 pm ET
Globe Newswire
January 02, 2019
7:00 am ET
Globe Newswire
December 02, 2018
12:00 pm ET
Globe Newswire
November 28, 2018
7:00 am ET
Globe Newswire
November 19, 2018
7:00 am ET
Globe Newswire
November 15, 2018
8:15 am ET
Globe Newswire
November 05, 2018
4:05 pm ET
Globe Newswire
November 01, 2018
9:17 am ET
Globe Newswire
October 29, 2018
7:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.